4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbadis.2012.06.014PMID 22771891PMCID PMC3418427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.

  2012influential reference
• Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria.

  2012cited by this paper
• Glyoxal Formation and Its Role in Endogenous Oxalate Synthesis

  2012cited by this paper
• Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

  2011influential reference
• Structural and Biochemical Studies of Human 4-hydroxy-2-oxoglutarate Aldolase: Implications for Hydroxyproline Metabolism in Primary Hyperoxaluria

  2011influential reference
• A tetrameric structure is not essential for activity in dihydrodipicolinate synthase (DHDPS) from Mycobacterium tuberculosis.

  2011cited by this paper
• Disruption of quaternary structure in Escherichia coli dihydrodipicolinate synthase (DHDPS) generates a functional monomer that is no longer inhibited by lysine.

  2010cited by this paper
• Mutations in DHDPSL are responsible for primary hyperoxaluria type III.

  2010influential reference
• The C-terminal domain of Escherichia coli dihydrodipicolinate synthase (DHDPS) is essential for maintenance of quaternary structure and efficient catalysis.

  2009cited by this paper
• The primary hyperoxalurias.

  2009cited by this paper
• Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis.

  2008cited by this paper
• Mutating the tight-dimer interface of dihydrodipicolinate synthase disrupts the enzyme quaternary structure: toward a monomeric enzyme.

  2008cited by this paper
• 4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria?

  2006cited by this paper
• Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase.

  2006cited by this paper
• Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

  2006cited by this paper
• Molecular Etiology of Primary Hyperoxaluria Type 1: New Directions for Treatment

  2005cited by this paper
• A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism.

  2005cited by this paper
• Structure-guided saturation mutagenesis of N-acetylneuraminic acid lyase for the synthesis of sialic acid mimetics.

  2005cited by this paper
• Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.

  2003influential reference
• Mimicking natural evolution in vitro: An N-acetylneuraminate lyase mutant with an increased dihydrodipicolinate synthase activity

  2003influential reference
• Characterization of the human heart mitochondrial proteome

  2003cited by this paper
• Primary hyperoxaluria type 1 in the Canary Islands: A conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase

  2003influential reference
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Role of mitochondrial lactate dehydrogenase and lactate oxidation in the intracellular lactate shuttle.

  1999cited by this paper
• Glyoxylate synthesis, and its modulation and influence on oxalate synthesis.

  1998cited by this paper
• Expression and Purification of Maltose‐Binding Protein Fusions

  1994cited by this paper
• Metabolism of proline and the hydroxyprolines.

  1980cited by this paper
• Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline.

  1979cited by this paper
• Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady‐state enzyme systems. Author: Irwin H. Segal (University of California, Davis). Published by Wiley‐Interscience, New York, 1975. Price: $24.50. No. of pages: 957

  1976cited by this paper

• Expanding the Alkene‐Forming Capability of the Pseudomonas Savastanoi Ethylene‐Forming Enzyme

  2026cites this paper
• Unraveling the genetic underpinnings of mitochondrial traits and associated circulating inflammatory proteins in Alzheimer's disease: Mitochondrial HtrA2-T cell CD5 negative axis

  2025cites this paper
• Normal urinary oxalate excretion in 4-hydroxy-2-oxo-glutarate aldolase (HOGA1) deficient mice with AGT expression in peroxisomes and not in mitochondria.

  2025cites this paper
• Characterization of CHK-336, A First-in-Class, Liver-Targeted, Small Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria Treatment.

  2025cites this paper
• Host immunosenescence compromises Mycobacterium tuberculosis clearance

  2025cites this paper
• Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory

  2024cites this paper
• Human glyoxylate metabolism revisited: New insights pointing to multi‐organ involvement with implications for siRNA‐based therapies in primary hyperoxaluria

  2024cites this paper
• Metallomic Approach to Mercury and Selenium in the Liver Tissue of Psectrogaster amazonica and Raphiodon vulpinus from the Brazilian Amazon

  2024cites this paper
• 4-hydroxy-2-oxoglutarate metabolism in a mouse model of Primary Hyperoxaluria Type 3

  2024cites this paper
• Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs

  2024cites this paper
• A molecular journey on the pathogenesis of primary hyperoxaluria

  2024cites this paper
• Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2

  2023cites this paper
• Genotype and Phenotype Characteristics of Chinese Pediatric Patients with Primary Hyperoxaluria

  2023cites this paper
• HOGA1 variants in Chinese patients with primary hyperoxaluria type 3: genetic features and genotype–phenotype relationships

  2023cites this paper
• Combined liver‐kidney transplantation in pediatric patients

  2023cites this paper
• A review on the pharmacotherapy and case studies of hypercalciuria and hyperoxaluria

  2022influential citation
• Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.

  2022cites this paper
• HOGA1 gene pathogenic variants in primary hyperoxaluria type III: Spectrum of pathogenic sequence variants, and phenotypic association

  2022cites this paper
• Integrative Functional Genomic Analysis in Multiplex Autism Families from Kazakhstan

  2022cites this paper
• Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment

  2022cites this paper
• Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria

  2021cites this paper
• Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention

  2021cites this paper
• Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.

  2020cites this paper
• Future treatments for hyperoxaluria Copyrigh

  2020cites this paper
• Novel therapeutic approaches for the primary hyperoxalurias

  2020cites this paper
• Metabolism oxalic acid: failure causes and consequences of molecular-biochemical factors for the formation of oxalate-induced diseases

  2019cites this paper
• From pathogenesis to novel therapies in primary hyperoxaluria

  2019cites this paper
• Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population

  2019cites this paper
• Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.

  2019cites this paper
• The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.

  2019cites this paper
• Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children

  2019cites this paper
• Future treatments for hyperoxaluria.

  2019cites this paper
• Regulation of human 4-hydroxy-2-oxoglutarate aldolase by pyruvate and α-ketoglutarate. Implications for Primary Hyperoxaluria Type-3.

  2019cites this paper
• Transfert de gènes dans les cellules souches pluripotentes induites : application à la thérapie génique de l'hyperoxalurie primitive de type 1

  2018cites this paper
• Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

  2018cites this paper
• Folding Defects Leading to Primary Hyperoxaluria.

  2018cites this paper
• Targeting Trafficking in Drug Development

  2018cites this paper
• Metabolite diagnosis of primary hyperoxaluria type 3

  2018cites this paper
• Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria

  2018cites this paper
• Dihydrodipicolinate synthase is absent in fungi.

  2018cites this paper
• Targeting kidney inflammation as a new therapy for primary hyperoxaluria?

  2018cites this paper
• Molecular basis of primary hyperoxaluria: clues to innovative treatments

  2018cites this paper
• Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria

  2018cites this paper
• HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients

  2017cites this paper
• Hyperoxaluria, hyperglycoluria and renal oxalosis in Gilbert's potoroos (Potorous gilbertii).

  2017influential citation
• Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism

  2017cites this paper
• Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III

  2017cites this paper
• Dihydrodipicolinate Synthase: Structure, Dynamics, Function, and Evolution.

  2017cites this paper
• Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria

  2016cites this paper
• Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.

  2016cites this paper
• GC-MS INVESTIGATION OF METABOLIC ACTIVITY IN 4-HYDROXY-2-OXOGLUTARATE ALDOLASE DEFICIENCY OF PRIMARY HYPEROXALURIA TYPE 3 BY JORDAN

  2016cites this paper
• Cellular degradation of 4‐hydroxy‐2‐oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3

  2016cites this paper
• A genetic perspective on rapid evolution in cane toads (Rhinella marina)

  2015cites this paper
• Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

  2015cites this paper
• Molecular basis of primary hyperoxaluria and strategies for diagnosis

  2015influential citation
• Primary and secondary hyperoxaluria: Understanding the enigma World of Nephrology

  2015cites this paper
• Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3.

  2015cites this paper
• Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria.

  2015cites this paper
• 4-hydroxyglutamate is a biomarker for primary hyperoxaluria type 3.

  2015influential citation
• Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3

  2015cites this paper
• Primary and secondary hyperoxaluria: Understanding the enigma.

  2015cites this paper
• Primary hyperoxalurias: diagnosis and treatment

  2015cites this paper
• Renal function can be impaired in children with primary hyperoxaluria type 3

  2015cites this paper
• HIPEROKSALURIJA U DJECE

  2014cites this paper
• Molecular studies to investigate 4-hydroxy-2-oxoglutarate metabolism defects of primary hyperoxaluria type 3

  2014cites this paper
• Nephrocalcinosis in childhood

  2014cites this paper
• Organtransplantation bei Patienten mit primärer Hyperoxalurie

  2014cites this paper
• Primary hyperoxaluria – An update

  2014cites this paper
• Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions

  2013influential citation
• Primary hyperoxaluria.

  2013cites this paper
• Update on Oxalate Crystal Disease

  2013cites this paper